The board of directors of Baxter International Inc. (NYSE:BAX) authorised a quarterly dividend of USD0.28 per share of its common stock, the company declared on Tuesday.
This cash dividend is due on 3 January 2022 to shareholders of record as of 3 December 2021.
Annually, the dividend rate is equivalent to USD1.12 per share of the company's common stock.
Baxter is a medical products company that provides a portfolio of critical care, nutrition, renal, hospital and surgical products, products, technologies and therapies in more than 100 countries.
Bruker Corporation to acquire ELITechGroup for EUR870m, strengthening MDx portfolio
Perrigo announces quarterly dividend increase
Bruker expands Preclinical Imaging Portfolio with acquisition of Spectral Instruments Imaging
Fusion Antibodies announces receipt of follow-on project and provides R&D update
Alvotech reports positive results for AVT03, potential biosimilar to Prolia and Xgeva
Biosenic finalises agreement with Phebra for oral arsenic troxide development